Effectiveness and safety of lidocaine patch 5%
Galer, B.S.
Journal of family practice 51(10): 867-8; author reply 868
2002
ISSN/ISBN: 0094-3509 PMID: 12401158 Document Number: 547268
Document emailed within 1 workday
Related Documents
López-Cepero, R.; Lynch, L.; de la Vega, A. 2013: Effectiveness and safety of lidocaine in the induction of fetal cardiac asystole for second trimester pregnany termination Boletin de la Asociacion Medica de Puerto Rico 105(1): 14-17Kaunitz, A.; Archer, D.; Foegh, M. 2012: Safety and tolerability of the agile patch, a contraceptive patch with low-dose ethinyl estradiol (EE) and levonorgestrel (LNG), vs. combination oral contraceptives (COCs) in obese vs. non-obese women Fertility and Sterility 98(3): S195-S196
Kaufmann, J.M.; Hale, E.K.; Ashinoff, R.A.; Cohen, D.E. 2002: Cutaneous lidocaine allergy confirmed by patch testing Journal of Drugs in Dermatology: Jdd 1(2): 192-194
Casale, R.; Polati, E.; Schweiger, V.; Coluzzi, F.; Bhaskar, A.; Consalvo, M. 2014: Localized neuropathic pain--5% lidocaine medicated patch as a first-line treatment and as add-on therapy: literature review and personal experience Minerva Medica 105(3): 177-195
Tobias, M.D.; Pilla, M.A.; Rogers, C.; Jobes, D.R. 1996: Lidocaine inhibits blood coagulation: implications for epidural blood patch Anesthesia and Analgesia 82(4): 766-769
Hashiguchi, A.; Kano, T.; Nakamura, M.; Shibata, Y.; Sasaoka, Y.; Matsuyama, K.; Morioka, T.; Mishima, M.; Yasutake, S.; Nakano, M. 1990: Dermal patch anesthesia to prevent pain from dermal puncture--10% lidocaine aqueous gel with 3% glycyrrhetinic acid 3-0 hemiphthalate disodium Masui. Japanese Journal of Anesthesiology 39(4): 473-477
Nestor, M.S. 2006: Safety of occluded 4% liposomal lidocaine cream Journal of Drugs in Dermatology: Jdd 5(7): 618-620
Murty, J.; Firth, S. 1996: Effect of CSM's warning about safety of third generation oral contraceptives. Contraceptive effectiveness may be being sacrificed for safety Bmj 313(7053): 363
Stevermer, J. 1996: Cost-effectiveness of the nicotine patch Journal of Family Practice 43(2): 125-126
Jarupanich, T.; Lamlertkittikul, S.; Chandeying, V. 2003: Efficacy, safety and acceptability of a seven-day, transdermal estradiol patch for estrogen replacement therapy Journal of the Medical Association of Thailand 86(9): 836-845
Baumann, L.S.; Grunebaum, L.; Elsaie, M.L.; Murdock, J.; Jablonka, E.; Figueras, K.; Bell, M. 2010: Safety and efficacy of a rapid-acting topical 4% lidocaine gel in a unique drug delivery system Journal of Drugs in Dermatology: Jdd 9(12): 1500-1504
Pongprasobchai, S.; Jiranantakan, T.; Nimmannit, A.; Nopmaneejumruslers, C. 2007: Comparison of the efficacy between lidocaine spray plus lidocaine jelly lubrication and lidocaine jelly lubrication alone prior to nasogastric intubation: a prospective double-blind randomized controlled study Journal of the Medical Association of Thailand 90(Suppl 2): 41-47
Arregui-Martínez de Lejarza, L.M.; Vigil, M.D.; Pérez Pascual, M.C.; Cardona-Valdés, A.; Pérez de Cossío, J.M. 1997: Evaluation of the analgesic effectiveness of ketorolac in intravenous regional anesthesia induced by lidocaine Revista Espanola de Anestesiologia y Reanimacion 44(9): 341-344
Li, J.; Wei, W.; Yang, W.; Li, J.; Gao, Y.; Qian, Y. 2018: Comparison of clinical efficacy and safety between articaine and lidocaine in the anaesthesia management of tooth pulp disease Pakistan Journal of Pharmaceutical Sciences 31(5(Special): 2303-2306
Sinkiewicz, W.; Marzec, A.; Hoffman, A.; Jankowski, A.; Bartuzi, Z.; Romański, B. 1989: Therapeutic effectiveness of lidocaine in patients with ventricular arrhythmias estimated relative to measurements of drug concentration in serum Kardiologia Polska 32(7-9): 366-371
Sargin, M.A.; Yassa, M.; Celik, A.; Ergun, E.; Tug, N. 2017: Lidocaine and tenoxicam effectiveness for pain relief during Pipelle: Non-randomised double-blind placebo-controlled trial JPMA. Journal of the Pakistan Medical Association 67(4): 527-533
Wainwright, R.J.; Foran, J.P.; Padaria, S.F.; Akhras, F.; Jackson, G.; Clark, A.R. 1993: The long-term safety and tolerability of transdermal glyceryl trinitrate, when used with a patch-free interval in patients with stable angina British Journal of Clinical Practice 47(4): 178-182
Zhang, C.; Li, H.; Xiong, X.; Zhai, S.; Wei, Y.; Zhang, S.; Zhang, Y.; Xu, L.; Liu, L. 2017: An open-label, two-period comparative study on pharmacokinetics and safety of a combined ethinylestradiol/gestodene transdermal contraceptive patch Drug Design Development and Therapy 11: 725-731
Wiegratz, I.; Bassol, S.; Weisberg, E.; Mellinger, U.; Merz, M. 2014: Effect of a low-dose contraceptive patch on efficacy, bleeding pattern, and safety: a 1-year, multicenter, open-label, uncontrolled study Reproductive Sciences 21(12): 1518-1525
Muti, G.F.. 2019: Open-Label, Post-Marketing Study to Evaluate the Performance and Safety of Calcium Hydroxylapatite With Integral Lidocaine to Correct Facial Volume Loss Journal of Drugs in Dermatology: Jdd 18(1): 86-91